Supplementary Material For: Immunotherapy-Induced Scarring Alopecia: A Case Series

    March 2026 in “ Figshare
    figshare admin karger, ElInkichari D., Sboui K., Donzel M., Ribereau-Gayon E., Fathallah R., N. S. DALLE
    Image
    Studysummary In this study, researchers reported a 1.33% prevalence of scarring alopecia among 450 patients treated with immune checkpoint inhibitors for metastatic melanoma, noting that hair loss did not require treatment discontinuation and seemed to coincide with favorable cancer outcomes.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →